Dr. Zbigniew Zaslona currently serves as the Chief Scientific Officer at Molecure. He obtained his PhD in 2010 at the University of Giessen and the Marburg Lung Center in Germany, studying the mechanisms that modulate innate immunity in the context of pneumonia. He then completed his postdoctoral training at the University of Michigan, where he focused on pharmacological studies of GPCR receptors, particularly lipid mediators of inflammation. From 2015 to October 2020, he was a research fellow at the Department of Biochemistry and Immunology, Trinity College Dublin (Ireland), as well as a Senior Investigator at the UK Biotechnology Company Sitryx where he was responsible for anti-inflammatory drug development programs.
